These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2012-000181-37||A Randomized, Placebo-Controlled Phase 2 Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CVT-301 (Levodopa Inhalation Powder) in Patients with Parkinson’s Disease and Motor Response Flu...||2012-11-29||due-trials|
|Reported results||2012-005822-31||A Phase 2b, Randomized, Double-blind, Placebo-controlled Study Investigating the Efficacy and Safety of Inhaled CVT 301 (Levodopa Inhalation Powder) in Parkinson’s Disease Patients With Motor Response...||2014-02-28||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2014-003799-22||A Phase 3, Randomized Study Investigating the Safety of||2017-05-16||bad-data|
|Listed as ongoing, but also has a completion date||2014-005630-60||A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study with an Open-Label Phase to Determine the Efficacy and Safety of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patien...||2018-01-12||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2015-005067-17||A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Investigating the Efficacy and Safety of CVT-301 (Levodopa Inhalation Powder) in Parkinson?s Disease Patients With Motor Response Fluctuat...||2016-12-06||bad-data|
|Completed, report not yet due||2015-005626-19||A 12 Month, Dose-Level Blinded Study Investigating the Safety and Efficacy of CVT-301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)||2018-05-23||not-yet-due|